VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
CAH
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
CAHCardinal Health, Inc.
$228.30$53.5B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCAHCash Flow

Cardinal Health, Inc. (CAH) Cash Flow Statement

30Y historyFree accessUpdated daily

Cash flow generation is highly volatile due to working capital changes, as seen in the $2.3B drain in 2025Q1, and capital allocation has prioritized acquisitions with over $7.5B net deployed over the last ten quarters.

Income StatementBalance SheetCash FlowRatios

CAH Cash Flow Statement

Annual statement

CAH Cash Flow Statement

Cardinal Health, Inc. (CAH) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricDec'25Jun'25Jun'24Jun'23Jun'22Jun'21Jun'20Jun'19Jun'18Jun'17Jun'16Jun'15Jun'14Jun'13Jun'12Jun'11Jun'10Jun'09Jun'08Jun'07Jun'06Jun'05Jun'04Jun'03Jun'02Jun'01Jun'00Jun'99Jun'98Jun'97
Cash from Operations5.17B2.4B3.76B2.84B3.12B2.43B1.96B2.72B2.77B1.18B2.97B2.54B2.52B1.73B1.18B1.39B2.13B1.57B1.51B1.22B2.14B2.85B2.62B1.4B983.9M871.7M638.2M345.7M143.1M39.2M
Operating CF Margin %8.13%1.08%1.66%1.39%1.72%1.5%1.28%1.87%2.02%0.91%2.44%2.48%2.77%1.71%1.09%1.36%2.17%1.63%1.73%1.41%2.69%3.92%4.07%2.46%1.92%1.82%1.66%1.38%0.68%0.21%
Operating CF Growth %115.85%-36.28%32.28%-8.9%28.53%23.93%-27.99%-1.66%133.78%-60.15%16.97%0.63%46.15%46.85%-15.67%-34.65%36.16%3.65%23.63%-42.85%-24.91%8.59%87.75%42.09%12.87%36.59%84.61%141.58%265.05%-67.92%
Net Income1.71B1.57B853M331M-933M612M-3.69B1.36B259M1.29B1.43B1.21B1.16B335M1.07B966M587M758.2M847.2M1.93B1B1.05B1.52B1.38B1.14B857.4M717.8M481M448.5M334.8M
Depreciation & Amortization956M790M710M692M723M783M913M1B1.03B717M641M451M459M397M325M313.3M254.4M399.4M381.3M322.1M392.7M409.7M299.2M265.8M243.5M280.6M245.9M233.5M64.3M51.3M
Stock-Based Compensation367M244M121M96M089M90M82M85M96M111M110M96M93M85M79.5M99.5M122.8M122.3M138.1M237.3M000000000
Deferred Taxes91M243M-104M-40M7M496M-961M-83M-1.01B291M87M219M26M21M158M128M120M69.5M26.9M11.7M-5.7M54.7M102.8M215.2M239.7M149.1M128.5M132.4M90.1M32.9M
Other Non-Cash Items-31M74M672M1.31B2.2B160M-450M-397M1.5B53M78M96M25M890M-28M-46M198M617.9M461.2M-605.5M671.8M455.6M-19M22.2M42.6M41.4M37.5M29.7M23.4M8.6M
Working Capital Changes2.09B-523M1.51B457M1.12B289M6.06B755M907M-1.27B623M452M755M-9M-434M-46M875M-357.4M-121.5M-436.3M157M999.1M733.2M-486.4M-682.7M-456.8M-636.8M-503.7M-208.4M-96.4M
Change in Receivables-408M-833M-996M-950M-1.53B-904M82M-751M-871M-665M-866M-870M925M216M-129M-457M21M-713.6M-296.1M-783.1M-895.3M-15.9M-411.7M-413.7M142.7M-31.4M-377.3M-214.5M-211.7M-15.3M
Change in Inventory-488M-1.82B1.11B-412M-1.07B-1.58B-409M-551M-1.21B-673M-1.18B-779M142M-370M-495M-665M477M-431.2M634.3M217.4M-356.1M71.6M237.5M-217.9M-1.07B-1.52B-1.07B-317.9M-474.3M-106.6M
Change in Payables3.46B2.73B1.82B2.82B3.43B2.33B-162M1.86B2.57B564M2.81B1.95B-196M426M319M1.36B451M768.1M-848.2M00000000000
Cash from Investing-2.58B-5.61B-1.85B-454M567M-378M493M338M-5.61B-405M-4.08B-849M-850M-2.38B-377M-2.03B127.1M-542.9M-726.4M1.54B-1.19B-877.4M-2.44B-343.7M-650.9M-633.4M-287.3M-409.6M-112.2M-17.9M
Capital Expenditures-649M-547M-511M-481M-387M-400M-375M-328M-384M-387M-465M-300M-249M-195M-263M-291.3M-255.8M-533.4M-376.1M-357.4M-443.2M-571.7M-410.2M-423.2M-285.4M-341.2M-307.8M-467.4M-114.7M-75.2M
CapEx % of Revenue1.02%0.25%0.23%0.23%0.21%0.25%0.25%0.23%0.28%0.3%0.38%0.29%0.27%0.19%0.24%0.28%0.26%0.56%0.43%0.41%0.56%0.79%0.64%0.75%0.56%0.71%0.8%1.86%0.54%0.41%
Acquisitions-1.99B-5.25B-1.19B-10M901M-3M0-82M-6.14B-132M-3.61B-503M-519M-2.24B-174M-2.3B-32M-128.6M-4.7M-1.63B-362.2M-273.2M-2.09B-26.8M-383.8M-364.3M-69.6M-147.5M-45.8M0
Investments------------------------------
Other Investing15M-10M18M8M31M02M763M862M3M13M53M0003M148M-6M-697.9M3.16B-86.6M-163.2M48.7M106.3M18.3M72.1M60.2M57.9M6.1M23.5M
Cash from Financing-1.6B1.95B-847M-3.05B-2.46B-1.32B-2.2B-2.29B-2.28B3.75B-1.14B60M-710M275M-454M-192.6M-727.5M-468.2M-803.2M-2.64B-1.03B-1.66B-815.7M-712.3M114.9M108.7M-31.7M-141.8M31M-82.5M
Debt Issued (Net)337M3.22B356M-579M-885M-570M-1.4B-1.1B-1B4.86B20M1.44B112M980M258M312M-1.49B-304.2M296.4M630.5M299.8M-1.21B512.8M326.9M333M32.6M372.7M-102.2M-26.9M-368.5M
Equity Issued (Net)-1.36B-765M-750M-2B-1B-200M-350M-600M-550M-600M-651M-1.04B-673M-329M-408M-207M-190M39.2M-953.7M-3.11B-1.26B-389.8M-1.28B-994.4M-168.3M112.7M-243.9M14.3M-95.8M70.5M
Dividends Paid-491M-494M-499M-525M-559M-573M-569M-577M-581M-577M-512M-460M-415M-353M-300M-274.2M-253.1M-200.4M-173.1M-144.4M-101.8M-51.7M-52.3M-44.8M-45M-36.6M-28M-56.7M-11.5M-9.1M
Share Repurchases-1.36B-765M-750M-2B-1B-200M-350M-600M-550M-600M-651M-1.04B-673M-450M-450M-270M-230M0-1.18B-3.66B-1.5B-500.3M-1.5B-1.19B-308.3M-139.4M-341.4M-47.8M-155M-37.7M
Other Financing-90M-13M46M53M-19M26M120M-14M-144M59M4M117M266M-23M-4M-23.4M1.2B-2.8M27.2M-15.5M28.9M-6.9M7.1M0-4.8M0-130.5M-19M-40.8M-41.7M
Net Change in Cash982M-1.26B1.06B-669M1.31B636M240M768M-5.12B4.52B-2.26B1.75B964M-373M345M-826M1.53B556.2M-17.5M121.5M-79.1M315.7M-628M342M447.9M347M319.2M-208.1M61.9M-61.2M
Free Cash Flow4.53B1.85B3.25B2.36B2.73B2.03B1.58B2.39B2.38B797M2.51B2.24B2.27B1.53B913M1.1B1.88B1.03B1.14B865.7M1.7B2.28B2.21B974.8M698.5M530.5M330.4M-121.7M28.4M-36M
FCF Margin %7.11%0.83%1.43%1.15%1.51%1.25%1.04%1.65%1.74%0.61%2.06%2.18%2.5%1.52%0.85%1.07%1.91%1.08%1.3%1%2.13%3.14%3.43%1.72%1.37%1.11%0.86%-0.48%0.13%-0.2%
FCF Growth %144.59%-43.09%37.58%-13.6%34.8%28.01%-33.79%0.42%199.12%-68.2%11.88%-1.54%48.5%67.8%-17.25%-41.26%81.67%-8.99%31.22%-48.99%-25.52%2.89%127.17%39.56%31.67%60.56%371.49%-528.52%178.89%-173.32%
FCF per Share19.267.6413.169.029.806.905.417.957.572.497.596.696.594.452.623.135.202.863.122.143.965.235.152.151.541.140.73-0.280.07-0.15
FCF Conversion (FCF/Net Income)13.00x1.54x4.42x8.62x-3.33x3.98x-0.53x2.00x10.81x0.92x2.08x2.09x2.16x5.17x1.10x1.45x3.32x1.36x1.16x0.63x2.14x2.71x1.78x0.99x0.93x1.02x0.94x0.76x0.58x0.22x
Interest Paid406M315M214M203M0182M226M285M320M200M174M150M152M128M118M116M158M201.8M239.8M00000000000
Taxes Paid338M444M191M156M0273M368M311M425M686M635M529M632M899M513M588M514M429.3M116M00000000000

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Working capital volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q4)

Earnings Quality Eroded by Working Capital Swings

Operating cash flow frequently diverges from net income, exemplified by a negative $1.6B OCF in 2025Q1 despite $416M net income, as reported in cash flow statements, highlighting severe distortions from inventory and receivables timing.

The OCF/NI ratio has been wildly inconsistent, ranging from -3.96 to 8.80 over ten quarters, indicating that reported earnings are an unreliable proxy for cash generation. This volatility is primarily driven by massive, unpredictable working capital swings, which suggest the business model creates inherent cash flow instability that obscures underlying operational performance.

FCF Swings Undermine Capital Return Capacity

Free cash flow has been erratic, plunging to -$1.7B in 2025Q1 before surging to $2.8B in 2025Q3, per the provided data, reflecting how working capital and acquisition timing overwhelm core operational cash generation.

Despite recent strong quarters, the historical pattern of negative FCF quarters implies that the company's ability to consistently fund dividends and buybacks may be constrained during periods of working capital expansion. The volatile trajectory complicates long-term financial planning and suggests that reported net income is not translating into predictable, sustainable free cash flow.

Extreme WC Swings Dominate Cash Profile

Working capital changes have swung from a $2.3B cash drain in 2025Q1 to a $1.2B source in 2026Q4, as shown in the financial data, demonstrating that inventory and receivables management are the primary drivers of quarterly cash flow volatility.

These massive fluctuations, often exceeding net income by several times, indicate a structural vulnerability in the high-volume distribution model where short-term cash positioning is dictated by payment cycles with suppliers and customers. The lack of stability in this metric suggests investors should focus on multi-year cash flow trends rather than quarterly figures, as single-period results are heavily distorted.

Acquisition-Focused Allocation Amidst Cash Uncertainty

Over the last ten quarters, Cardinal Health deployed over $7.5B net for acquisitions and over $2.8B for share repurchases, based on cash flow data, while maintaining a steady quarterly dividend near $120M.

The significant acquisition outflows, particularly the $2.8B in 2025Q3, indicate a continued reliance on M&A for growth, which is a capital-intensive strategy that exacerbates cash flow volatility. The commitment to dividends and buybacks despite erratic free cash flow implies management is willing to utilize balance sheet capacity to return capital, a practice that warrants monitoring for sustainability if core cash generation does not stabilize.

Non-Cash Items and Litigation Cloud True Cash Generation

Stock-based compensation totaled $751M over the past ten quarters, and opioid-related litigation charges are excluded from operating cash flow, as noted in SEC filings, which may overstate the recurring cash-generating power of the core business.

While SBC is a non-cash charge, its substantial and growing total represents real economic dilution to shareholders that is not captured in standard free cash flow metrics. Furthermore, the exclusion of large, episodic litigation settlement payments from operating cash flow creates a cleaner but potentially misleading picture of normalized cash generation, requiring careful adjustment to assess the true underlying cash flow of the distribution operations.

CAH — Frequently Asked Questions

Quick answers to the most common questions about buying CAH stock.

How much cash does Cardinal Health, Inc. (CAH) generate from operations?

Cardinal Health, Inc. (CAH) generated $5.17B in net cash from operating activities in 2026. This reflects the cash generated directly from core business operations.

What is Cardinal Health, Inc.'s free cash flow?

Cardinal Health, Inc. (CAH) generated $4.53B in free cash flow in 2026. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Cardinal Health, Inc.'s capital expenditure (CapEx)?

Cardinal Health, Inc. (CAH) spent $649.0M on capital expenditures in 2026. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Cardinal Health, Inc. distribute cash to shareholders?

In 2026, Cardinal Health, Inc. (CAH) returned $491.0M to shareholders via cash dividends and spent $1.36B on share repurchases. This shows the company's commitment to returning capital to its equity investors.